Home Orexigen Therapeutics resubmits Contrave to FDA
 

Keywords :   


Orexigen Therapeutics resubmits Contrave to FDA

2013-12-12 11:39:48| Biotech - Topix.net

The FDA refused to approve Contrave in 2011, citing concerns over cardiovascular risk.

Tags: fda therapeutics

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
25.111/18CTS-V
25.11
25.111
25.11ARS 10+ EHERO 3
25.11 16MGL HG
25.11
25.11GREENMAX 4470 22600Ace4
25.11
More »